This is the text extract for Notification of acceptance of agreement with Regional Health., browse documents here.

20 August 2010

Agreement with Regional Health approved

PHARMAC is pleased to announce the approval of an agreement with Regional Health Limited for a range of radiological contrast media. This was the subject of a consultation letter dated 30 July 20101. Details of the change The CT Plus+ brand of barium sulphate will be listed on Section H of the Pharmaceutical Schedule from 1 September 2010, and Multihance and Ioscan will continue to be listed, with a small price increase for Ioscan. Details of these listings are as follows:

Chemical Gadobendate dimeglumine Gadobendate dimeglumine Sodium diotrizoate Barium sulphate Barium sulphate Presentation Solution for injection, 0.5 g per L, 10 mL Solution for injection, 0.5 g per L, 20 mL Oral solution, 3.705 g per 10 mL sachet Oral suspension, 2.2%, 250 mL bottle Oral suspension, 2.2%, 450 mL bottle Brand MultiHance MultiHance Ioscan CT Plus+ CT Plus+ Pack size 10 10 50 24 24 Price $324.74 $636.28 $156.12 $175.00 $220.00

None of the products would have Hospital Supply Status. Feedback received We appreciate all of the feedback that we received and acknowledge the time people took to respond. All consultation responses received by 12 August 2010 were considered in their entirety in making a decision on the proposed changes. All of the responses were supportive of the proposal. More information If you have any questions about this decision, you can call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.

1

Available at http://www.pharmac.govt.nz/consultation

A375239 Page 1 of 1